Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3D SHAPE for Monitoring Neoadjuvant Chemotherapy in Breast Cancer
NCT04715958Phase 3Active, not recruiting
- Start
- Apr 2021
- Primary completion
- Oct 2026
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in breast cancer. Primary endpoints: Calculation of tumor volume changes with neoadjuvant chemotherapy (NAC) at 48 months, Prediction of the patients' clinical and pathological response at 48 months and 1 more. Started Apr 2021; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04715958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715958.